Daruwala Paul

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(9%)(5%)(5%)(12%)0%
Sale Success Rate1 of 62 of 61 of 60 of 60 of 6

Cidara Therapeutics, Inc.

Drugs » Biotechnology

Chief Operating Officer:

Holdings: 221.1K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--